Summit Therapeutics Inc. (SMMT) NASDAQ
19.38
+0.46(+2.43%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
19.38
+0.46(+2.43%)
Currency In USD
| Market Cap | 13.08B |
| Enterprise Value | 12.87B |
| P/E Ratio | -13.42 |
| PEG Ratio | 0.79 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 21.99 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -17.75 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.44 |
| Return On Equity | -2.97 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -108,355 |
| EBITDA | -801.12M |
| Net Income | -1.08B |
| Diluted EPS | -1.44 |
| Total Cash | 713.45M |
| Total Cash/Share | 0.95 |
| Total Debt | 20.89M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 9.87 |
| Book Value Per Share | 0.88 |
| 52-Week Change | 11.89 |
| 52-Week High | 36.91 |
| 52-Week Low | 13.83 |
| Moving Average 50 Days | 15.9 |
| Moving Average 200 Days | 19.84 |
| Average Volume | 2.74M |
| Shares Outstanding | 744.44M |
| % Held by Institutions | 15.84 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |